Evidence map›Paper›PMID 38006081›Full record

ArticlePolymers2023

Challenges in Manufacturing of Hemp Fiber-Reinforced Organo Sheets with a Recycled PLA Matrix.

Maximilian Salmins, Florian Gortner, Peter Mitschang

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Maximilian SalminsLeibniz-Institut für Verbundwerkstoffe GmbH, Erwin-Schroedinger-Strasse 58, 67663 Kaiserslautern, Germany.ORCID 0000-0001-6593-8241
Florian GortnerLeibniz-Institut für Verbundwerkstoffe GmbH, Erwin-Schroedinger-Strasse 58, 67663 Kaiserslautern, Germany.
Peter MitschangLeibniz-Institut für Verbundwerkstoffe GmbH, Erwin-Schroedinger-Strasse 58, 67663 Kaiserslautern, Germany.ORCID 0000-0003-2650-6678
Leibniz-Institut für Verbundwerkstoffe GmbH · DE

Funding

Federal Ministry of Food and Agriculture 2220NR090C
6 · The paper itself

Abstract

This study investigates the influence of a hot press process on the properties of hemp fiber-reinforced organo sheets. Plain-woven fabric made from hemp staple fiber yarns is used as textile reinforcement, together with a recycled poly-lactic acid (PLA) matrix. Process pressure and temperature are considered with three factor levels for each parameter. The parameter influence is examined based on the B-factor model, which considers the temperature-dependent viscosity of the polymer, as well as the process pressure for the calculation of a dimensionless value. Increasing these parameters theoretically promotes improvements in impregnation. This study found that the considered recycled polymer only allows a narrow corridor to achieve adequate impregnation quality alongside optimal bending properties. Temperatures below 170 °C impede impregnation due to the high melt viscosity, while temperature increases to 185 °C show the first signs of thermal degradation, with reduced bending modulus and strength. A comparison with hemp fiber-reinforced virgin polypropylene, manufactured with identical process parameters, showed that this reduction can be mainly attributed to polymer degradation rather than reduction in fiber properties. The process pressure should be at least 1.5 MPa to allow for sufficient compaction of the textile stack, thus reducing theoretical pore volume content to a minimum.

Indexed as

B-factor modelhemp fibernatural fiber reinforced thermoplastic polymersorgano sheetrecycled PLA

Identifiers

PMID38006081
PMCPMC10674411
OpenAlexW4388490951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.